What is the current annual EBITDA of DXCM?

As of today, DXCM annual EBITDA is $1.16B

What is 1-year change in DXCM annual EBITDA?

DXCM annual EBITDA is up +42.30% year-over-year

What is 3-year change in DXCM annual EBITDA?

DXCM annual EBITDA is up +112.69% over the past 3 years

How far is DXCM annual EBITDA from its all-time high?

DXCM annual EBITDA is currently at its all-time high

How does DXCM annual EBITDA rank versus sector peers?

DXCM annual EBITDA is higher than 93.53% of companies in Healthcare sector

When is DXCM next annual earnings release?

The next annual earnings release for DXCM is on February 11, 2027

What is the current quarterly EBITDA of DXCM?

As of today, DXCM quarterly EBITDA is $401.70M

What is DXCM quarterly EBITDA most recent change?

DXCM quarterly EBITDA was up +3.93% on September 30, 2026

What is 1-year change in DXCM quarterly EBITDA?

DXCM quarterly EBITDA is up +31.23% year-over-year

How far is DXCM quarterly EBITDA from its all-time high?

DXCM quarterly EBITDA is currently at its all-time high

How does DXCM quarterly EBITDA rank versus sector peers?

DXCM quarterly EBITDA is higher than 94.33% of companies in Healthcare sector

When is DXCM next earnings release?

The next earnings release for DXCM is on February 11, 2027

What is the current TTM EBITDA of DXCM?

As of today, DXCM TTM EBITDA is $1.50B

What is DXCM TTM EBITDA most recent change?

DXCM TTM EBITDA was up +6.81% on September 30, 2026

What is 1-year change in DXCM TTM EBITDA?

DXCM TTM EBITDA is up +46.64% year-over-year

How far is DXCM TTM EBITDA from its all-time high?

DXCM TTM EBITDA is currently at its all-time high

How does DXCM TTM EBITDA rank versus sector peers?

DXCM TTM EBITDA is higher than 94.24% of companies in Healthcare sector

When is DXCM next earnings release?

The next earnings release for DXCM is on February 11, 2027

DexCom, Inc. (DXCM) EBITDA History & Chart Since 2000

Annual EBITDA

$1.16B$345.90M+42.30%

December 31, 2025

Summary

Current Value: As of today, DXCM annual EBITDA is $1.16B, up +42.30% on December 31, 2025
Historical Performance: DXCM annual EBITDA is up +112.69% over the past 3 years, up +217.40% over the past 5 years
All-Time High Comparison: DXCM annual EBITDA is currently at its all-time high
3-Year Low Comparison: DXCM annual EBITDA is +112.69% above its 3-year low of $547.10M reached on an earlier date
Sector Comparison: DXCM annual EBITDA is higher than 93.53% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

DXCM Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$1.16B	+42.3%	+112.7%	+217.4%	+2815.3%
Quarterly EBITDA	Sep 30, 26	$401.70M	+31.2%	+58.3%	+179.3%	+3363.2%
TTM EBITDA	Sep 30, 26	$1.50B	+46.6%	+121.7%	+226.2%	+3939.5%
Price	Nov 4, 26	$88.48	+49.3%	-9.2%	-44.3%	+4538.5%
PE Ratio	Nov 4, 26	34.68	+5.1%	-67.9%	-69.7%	–
Annual Revenue	Dec 31, 25	$4.66B	+15.6%	+60.2%	+142.0%	+9486.5%
Annual EPS	Dec 31, 25	$2.09	+46.7%	+161.8%	+65.1%	+961.6%
	Dec 31, 25	$911.80M	+52.0%	+133.1%	+204.4%	+2113.3%
Annual Net Income	Dec 31, 25	$836.30M	+45.1%	+145.1%	+69.4%	+1615.9%

EBITDA Highs

DXCM Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$1.16B	Dec 31, 25	at high
5Y	$1.16B	Dec 31, 25	at high
All	$1.16B	Dec 31, 25	at high

EBITDA Lows

DXCM Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$547.10M	N/A	+112.7%
5Y	$366.60M	N/A	+217.4%
All	-$151.80M	Dec 31, 18	+866.5%

EBITDA History

Year	Value	Change
2025	$1.16B	+42.3%
2024	$817.70M	+4.3%
2023	$783.70M	+43.2%
2022	$547.10M	+48.8%
2021	$367.70M	+0.3%
2020	$366.60M	+91.9%
2019	$191.00M	+225.8%
2018	-$151.80M	-782.6%
2017	-$17.20M	+64.8%
2016	-$48.90M	-5.6%
2015	-$46.30M	-253.4%
2014	-$13.10M	+32.5%
2013	-$19.40M	+60.2%

Year	Value	Change
2012	-$48.80M	-18.8%
2011	-$41.08M	+4.1%
2010	-$42.85M	+1.4%
2009	-$43.46M	+12.1%
2008	-$49.44M	-13.0%
2007	-$43.76M	+6.1%
2006	-$46.62M	-48.6%
2005	-$31.36M	-131.0%
2004	-$13.58M	-38.1%
2003	-$9.83M	-26.3%
2002	-$7.78M	-15.7%
2001	-$6.72M	-67.5%
2000	-$4.01M	-

FAQ

What is the current annual EBITDA of DXCM?: As of today, DXCM annual EBITDA is $1.16B
What is 1-year change in DXCM annual EBITDA?: DXCM annual EBITDA is up +42.30% year-over-year
What is 3-year change in DXCM annual EBITDA?: DXCM annual EBITDA is up +112.69% over the past 3 years
How far is DXCM annual EBITDA from its all-time high?: DXCM annual EBITDA is currently at its all-time high
How does DXCM annual EBITDA rank versus sector peers?: DXCM annual EBITDA is higher than 93.53% of companies in Healthcare sector
When is DXCM next annual earnings release?: The next annual earnings release for DXCM is on February 11, 2027

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$401.70M$15.20M+3.93%

September 30, 2026

Summary

Current Value: As of today, DXCM quarterly EBITDA is $401.70M, up +3.93% on September 30, 2026
Historical Performance: DXCM quarterly EBITDA is up +31.23% year-over-year, up +58.34% over the past 3 years
All-Time High Comparison: DXCM quarterly EBITDA is currently at its all-time high
3-Year Low Comparison: DXCM quarterly EBITDA is +161.52% above its 3-year low of $153.60M reached on March 31, 2024
Sector Comparison: DXCM quarterly EBITDA is higher than 94.33% of companies in Healthcare sector

Performance

DXCM Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 26	$401.70M	+3.9%	+31.2%	+58.3%	+179.3%
Annual EBITDA	Dec 31, 25	$1.16B	–	+42.3%	+112.7%	+217.4%
TTM EBITDA	Sep 30, 26	$1.50B	+6.8%	+46.6%	+121.7%	+226.2%
Price	Nov 4, 26	$88.48	+7.0%	+49.3%	-9.2%	-44.3%
PE Ratio	Nov 4, 26	34.68	+6.3%	+5.1%	-67.9%	-69.7%
Quarterly Revenue	Sep 30, 26	$1.34B	+2.8%	+11.2%	+37.9%	+106.8%
Quarterly EPS	Sep 30, 26	$0.72	+12.2%	+2.6%	+149.0%	+244.6%
	Sep 30, 26	$327.20M	+2.8%	+34.9%	+59.2%	+176.6%
Quarterly Net Income	Sep 30, 26	$275.10M	+10.4%	-3.1%	+127.9%	+215.1%

Quarterly EBITDA Highs

DXCM Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$401.70M	Sep 30, 26	at high
3Y	$401.70M	Sep 30, 26	at high
5Y	$401.70M	Sep 30, 26	at high
All	$401.70M	Sep 30, 26	at high

Quarterly EBITDA Lows

DXCM Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$306.10M	N/A	+31.2%
3Y	$153.60M	Mar 31, 24	+161.5%
5Y	$32.70M	Dec 31, 21	+1128.4%
All	-$156.00M	Dec 31, 18	+357.5%

Quarterly EBITDA History

Month	Value	Change
Sep 2026	$401.70M	+3.9%
Jun 2026	$386.50M	+19.9%
Mar 2026	$322.40M	-17.0%
Dec 2025	$388.20M	+26.8%
Sep 2025	$306.10M	+11.1%
Jun 2025	$275.60M	+42.3%
Mar 2025	$193.70M	-21.5%
Dec 2024	$246.70M	+19.0%
Sep 2024	$207.30M	-1.3%
Jun 2024	$210.10M	+36.8%
Mar 2024	$153.60M	-43.0%
Dec 2023	$269.40M	+6.2%
Sep 2023	$253.70M	+47.7%
Jun 2023	$171.80M	+93.5%
Mar 2023	$88.80M	-45.1%
Dec 2022	$161.70M	-13.4%
Sep 2022	$186.70M	+54.8%
Jun 2022	$120.60M	+54.4%
Mar 2022	$78.10M	+138.8%
Dec 2021	$32.70M	-77.3%
Sep 2021	$143.80M	+15.5%
Jun 2021	$124.50M	+86.4%
Mar 2021	$66.80M	-46.3%
Dec 2020	$124.40M	+10.6%
Sep 2020	$112.50M	+35.4%
Jun 2020	$83.10M	+78.3%
Mar 2020	$46.60M	-59.8%
Dec 2019	$115.80M	+68.1%
Sep 2019	$68.90M	+538.0%
Jun 2019	$10.80M	+340.0%
Mar 2019	-$4.50M	+97.1%
Dec 2018	-$156.00M	-818.9%
Sep 2018	$21.70M	+1,105.6%
Jun 2018	$1.80M	+107.3%
Mar 2018	-$24.70M	-252.5%
Dec 2017	$16.20M	+326.3%
Sep 2017	$3.80M	+139.2%
Jun 2017	-$9.70M	+73.6%
Mar 2017	-$36.70M	-1,368.0%
Dec 2016	-$2.50M	+82.6%
Sep 2016	-$14.40M	+11.1%
Jun 2016	-$16.20M	-2.5%
Mar 2016	-$15.80M	-436.2%
Dec 2015	$4.70M	+111.8%

Month	Value	Change
Sep 2015	-$39.70M	-3,870.0%
Jun 2015	-$1.00M	+90.3%
Mar 2015	-$10.30M	-357.5%
Dec 2014	$4.00M	+208.1%
Sep 2014	-$3.70M	+24.5%
Jun 2014	-$4.90M	+46.7%
Mar 2014	-$9.20M	-9,300.0%
Dec 2013	$100.00K	+103.2%
Sep 2013	-$3.10M	+65.6%
Jun 2013	-$9.00M	+1.1%
Mar 2013	-$9.10M	-38.3%
Dec 2012	-$6.58M	+56.5%
Sep 2012	-$15.12M	-14.7%
Jun 2012	-$13.18M	+7.3%
Mar 2012	-$14.22M	-26.8%
Dec 2011	-$11.21M	+8.9%
Sep 2011	-$12.31M	-89.5%
Jun 2011	-$6.50M	+41.3%
Mar 2011	-$11.06M	-20.7%
Dec 2010	-$9.17M	+26.3%
Sep 2010	-$12.43M	-16.4%
Jun 2010	-$10.68M	-1.0%
Mar 2010	-$10.57M	-17.6%
Dec 2009	-$8.99M	+18.2%
Sep 2009	-$10.99M	+14.1%
Jun 2009	-$12.79M	-19.7%
Mar 2009	-$10.69M	+10.7%
Dec 2008	-$11.97M	+9.9%
Sep 2008	-$13.28M	-4.1%
Jun 2008	-$12.75M	-8.2%
Mar 2008	-$11.79M	-5.5%
Dec 2007	-$11.17M	-2.8%
Sep 2007	-$10.87M	+0.3%
Jun 2007	-$10.90M	-0.6%
Mar 2007	-$10.83M	-1.4%
Dec 2006	-$10.69M	+21.8%
Sep 2006	-$13.66M	-20.2%
Jun 2006	-$11.36M	-28.3%
Mar 2006	-$8.86M	+27.6%
Dec 2005	-$12.23M	-87.7%
Sep 2005	-$6.52M	-5.2%
Jun 2005	-$6.19M	-3.6%
Mar 2005	-$5.97M	-

FAQ

What is the current quarterly EBITDA of DXCM?: As of today, DXCM quarterly EBITDA is $401.70M
What is DXCM quarterly EBITDA most recent change?: DXCM quarterly EBITDA was up +3.93% on September 30, 2026
What is 1-year change in DXCM quarterly EBITDA?: DXCM quarterly EBITDA is up +31.23% year-over-year
How far is DXCM quarterly EBITDA from its all-time high?: DXCM quarterly EBITDA is currently at its all-time high
How does DXCM quarterly EBITDA rank versus sector peers?: DXCM quarterly EBITDA is higher than 94.33% of companies in Healthcare sector
When is DXCM next earnings release?: The next earnings release for DXCM is on February 11, 2027

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$1.50B$95.60M+6.81%

September 30, 2026

Summary

Current Value: As of today, DXCM TTM EBITDA is $1.50B, up +6.81% on September 30, 2026
Historical Performance: DXCM TTM EBITDA is up +46.64% year-over-year, up +121.72% over the past 3 years
All-Time High Comparison: DXCM TTM EBITDA is currently at its all-time high
3-Year Low Comparison: DXCM TTM EBITDA is +121.72% above its 3-year low of $676.00M reached on an earlier date
Sector Comparison: DXCM TTM EBITDA is higher than 94.24% of companies in Healthcare sector

Performance

DXCM Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 26	$1.50B	+6.8%	+46.6%	+121.7%	+226.2%
Annual EBITDA	Dec 31, 25	$1.16B	–	+42.3%	+112.7%	+217.4%
Quarterly EBITDA	Sep 30, 26	$401.70M	+3.9%	+31.2%	+58.3%	+179.3%
Price	Nov 4, 26	$88.48	+7.0%	+49.3%	-9.2%	-44.3%
PE Ratio	Nov 4, 26	34.68	+6.3%	+5.1%	-67.9%	-69.7%
TTM Revenue	Sep 30, 26	$5.10B	+2.7%	+13.0%	+50.0%	+120.1%
TTM EPS	Sep 30, 26	$2.55	+0.7%	+42.0%	+182.6%	+83.5%
	Sep 30, 26	$1.22B	+7.4%	+57.4%	+141.8%	+231.5%
TTM Net Income	Sep 30, 26	$991.00M	-0.9%	+37.5%	+162.9%	+71.6%

TTM EBITDA Highs

DXCM TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.50B	Sep 30, 26	at high
3Y	$1.50B	Sep 30, 26	at high
5Y	$1.50B	Sep 30, 26	at high
All	$1.50B	Sep 30, 26	at high

TTM EBITDA Lows

DXCM TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$1.02B	N/A	+46.6%
3Y	$676.00M	N/A	+121.7%
5Y	$367.80M	Dec 31, 21	+307.5%
All	-$157.20M	Dec 31, 18	+1053.4%

TTM EBITDA History

Month	Value	Change
Sep 2026	$1.50B	+6.8%
Jun 2026	$1.40B	+8.6%
Mar 2026	$1.29B	+11.1%
Dec 2025	$1.16B	+13.8%
Sep 2025	$1.02B	+10.7%
Jun 2025	$923.30M	+7.6%
Mar 2025	$857.80M	+4.9%
Dec 2024	$817.70M	-2.7%
Sep 2024	$840.40M	-5.2%
Jun 2024	$886.80M	+4.5%
Mar 2024	$848.50M	+8.3%
Dec 2023	$783.70M	+15.9%
Sep 2023	$676.00M	+11.0%
Jun 2023	$609.00M	+9.2%
Mar 2023	$557.80M	+2.0%
Dec 2022	$547.10M	+30.9%
Sep 2022	$418.10M	+11.4%
Jun 2022	$375.20M	-1.0%
Mar 2022	$379.10M	+3.1%
Dec 2021	$367.80M	-20.0%
Sep 2021	$459.50M	+7.3%
Jun 2021	$428.20M	+10.7%
Mar 2021	$386.80M	+5.5%
Dec 2020	$366.60M	+2.4%
Sep 2020	$358.00M	+13.9%
Jun 2020	$314.40M	+29.9%
Mar 2020	$242.10M	+26.8%
Dec 2019	$191.00M	+336.4%
Sep 2019	-$80.80M	+36.9%
Jun 2019	-$128.00M	+6.6%
Mar 2019	-$137.00M	+12.8%
Dec 2018	-$157.20M	-1,148.0%
Sep 2018	$15.00M	+617.2%
Jun 2018	-$2.90M	+79.9%
Mar 2018	-$14.40M	+45.5%
Dec 2017	-$26.40M	+41.5%
Sep 2017	-$45.10M	+28.8%
Jun 2017	-$63.30M	+9.3%
Mar 2017	-$69.80M	-42.7%
Dec 2016	-$48.90M	-17.3%
Sep 2016	-$41.70M	+37.8%
Jun 2016	-$67.00M	-29.3%
Mar 2016	-$51.80M	-11.9%
Dec 2015	-$46.30M	+1.5%

Month	Value	Change
Sep 2015	-$47.00M	-327.3%
Jun 2015	-$11.00M	+26.2%
Mar 2015	-$14.90M	-8.0%
Dec 2014	-$13.80M	+22.0%
Sep 2014	-$17.70M	-3.5%
Jun 2014	-$17.10M	+19.3%
Mar 2014	-$21.20M	-0.5%
Dec 2013	-$21.10M	+24.0%
Sep 2013	-$27.78M	+30.2%
Jun 2013	-$39.80M	+9.5%
Mar 2013	-$43.99M	+10.4%
Dec 2012	-$49.10M	+8.6%
Sep 2012	-$53.73M	-5.5%
Jun 2012	-$50.92M	-15.1%
Mar 2012	-$44.24M	-7.7%
Dec 2011	-$41.08M	-5.2%
Sep 2011	-$39.04M	+0.3%
Jun 2011	-$39.16M	+9.7%
Mar 2011	-$43.34M	-1.1%
Dec 2010	-$42.85M	-0.4%
Sep 2010	-$42.68M	-3.5%
Jun 2010	-$41.24M	+4.9%
Mar 2010	-$43.35M	+0.3%
Dec 2009	-$43.46M	+6.4%
Sep 2009	-$46.44M	+4.7%
Jun 2009	-$48.73M	-0.1%
Mar 2009	-$48.69M	+2.2%
Dec 2008	-$49.79M	-1.6%
Sep 2008	-$48.99M	-5.2%
Jun 2008	-$46.58M	-4.2%
Mar 2008	-$44.72M	-2.2%
Dec 2007	-$43.76M	-1.1%
Sep 2007	-$43.28M	+6.1%
Jun 2007	-$46.07M	+1.0%
Mar 2007	-$46.53M	-4.4%
Dec 2006	-$44.56M	+3.3%
Sep 2006	-$46.10M	-18.3%
Jun 2006	-$38.95M	-15.3%
Mar 2006	-$33.79M	-9.3%
Dec 2005	-$30.91M	-65.4%
Sep 2005	-$18.68M	-53.6%
Jun 2005	-$12.17M	-103.6%
Mar 2005	-$5.97M	-

FAQ

What is the current TTM EBITDA of DXCM?: As of today, DXCM TTM EBITDA is $1.50B
What is DXCM TTM EBITDA most recent change?: DXCM TTM EBITDA was up +6.81% on September 30, 2026
What is 1-year change in DXCM TTM EBITDA?: DXCM TTM EBITDA is up +46.64% year-over-year
How far is DXCM TTM EBITDA from its all-time high?: DXCM TTM EBITDA is currently at its all-time high
How does DXCM TTM EBITDA rank versus sector peers?: DXCM TTM EBITDA is higher than 94.24% of companies in Healthcare sector
When is DXCM next earnings release?: The next earnings release for DXCM is on February 11, 2027

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

DXCM Official Website www.dexcom.com/global
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1093557/000109355726000027/0001093557-26-000027-index.htm
DXCM Profile on Yahoo Finance finance.yahoo.com/quote/DXCM
DXCM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dxcm